Fundraising FoxCapstar Ventures — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Gelesis develops an oral superabsorbent hydrogel platform (OHS) built from naturally derived materials that works locally in the GI tract to influence satiety signals and support metabolic health.
BiotechDigital HealthHealthtechWellness & FitnessBoston, US
Yishai Zohar(Director, President, and Chief Executive Officer)inElliot Maltz(Treasurer)in
BoardJohn LaMattina(Director)Elon Boms(Director)inMeghan Fitzgerald(Director)Robert Forrester(Director)in
Board seatKathryn Cavanaugh· per SEC Form D · $50.6M raise · filed Aug 2022
Co-investorsLaunchCapitalSalica InvestmentsInvescoOrbiMedPureTech HealthVitruvian Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Underscore USA, Inc.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.